99% Savings - Buy Just @1 Rs X
Fycompa 4 Mg Tablet (28) is a commercial drug that is prescribed in the form of Tablet. Seizures are some of its major therapeutic uses.
The optimal dosage of Fycompa 4 Mg Tablet (28) is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
The side effects typically associated with Fycompa 4 Mg Tablet (28) include Dizziness, Vertigo, Blurred vision. Normally, these side effects of Fycompa 4 Mg Tablet (28) are not long lasting and go away when the treatment is finished. However, if these continue for a longer time, consult your doctor right away.
Furthermore, you should know that effect of Fycompa 4 Mg Tablet (28) is Severe for pregnant women and Moderate for women who are breastfeeding. Further, the section on Fycompa 4 Mg Tablet (28) related warnings talks about Fycompa 4 Mg Tablet (28)'s effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Failure, Liver Disease must refrain from the use of Fycompa 4 Mg Tablet (28) since this can cause severe adverse effects. The section on Fycompa 4 Mg Tablet (28) contraindications lists all such conditions.
Drug reaction of Fycompa 4 Mg Tablet (28) with other medicines has been reported. See below for a complete list.
You should also be aware that Fycompa 4 Mg Tablet (28) is not safe while driving, and is not addiction.
Fycompa 4 Mg Tablet (28) is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Is the use of Fycompa 4 Mg Tablet (28) safe for pregnant women?
Fycompa can cause severe side effects if taken during pregnancy, so, pregnant women should talk to their doctor before taking it.
Is the use of Fycompa 4 Mg Tablet (28) safe during breastfeeding?
If you are breastfeeding, you may experience some harmful effects of Fycompa. In case you experience any of these, discontinue its use until you consult your doctor.
What is the effect of Fycompa 4 Mg Tablet (28) on the Kidneys?
Fycompa can have moderate side effects on the kidney. If you notice any harmful effects, stop taking this drug right away. Consult your doctor before using this medicine again.
What is the effect of Fycompa 4 Mg Tablet (28) on the Liver?
Use of Fycompa may be dangerous for the liver. Do not use it without doctor's advice.
What is the effect of Fycompa 4 Mg Tablet (28) on the Heart?
Fycompa is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Fycompa 4 Mg Tablet (28) unless your doctor advises you to do so -
Is this Fycompa 4 Mg Tablet (28) habit forming or addictive?
Yes, Fycompa 4 Mg Tablet (28) can get addictive. Consume it only after doctor's advise.
Is it safe to drive or operate heavy machinery when consuming?
After taking Fycompa 4 Mg Tablet (28), you should not drive or work on any heavy machine, as Fycompa 4 Mg Tablet (28) can make you drowsy.
Is it safe?
Yes, but consume Fycompa 4 Mg Tablet (28) only on doctor's advice.
Is it able to treat mental disorders?
Yes, taking Fycompa 4 Mg Tablet (28) can treat mental disorders.
Interaction between Food and Fycompa 4 Mg Tablet (28)
Taking Fycompa 4 Mg Tablet (28) with food does not harm your health.
Interaction between Alcohol and Fycompa 4 Mg Tablet (28)
Consumption of alcohol and Fycompa 4 Mg Tablet (28) together may have severe effects on your health.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Fycompa® (perampanel)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1010-1012